In this context, we have evaluated the mutational status of PIK3CA and AKT1genes in bladder cancer biopsies and matched urines, and assess their use as anon-invasive molecular biomarker for patients ́ diagnosis and monitoring. This evidence concerns the gene PIK3CA and urinary bladder carcinoma.